Treace Medical Concepts, Inc. (TMCI) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

From a roadmap perspective, the setup is boxed by support near 1.80 and resistance around 3.67. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.

📊 Technical Summary

Treace Medical Concepts, Inc. (TMCI) closed at 1.94 (+3.74%). Price has recovered above the 50-day average but remains below the 200-day average, so the short-term tone is improving while the larger structure is still rebuilding. 20-day momentum is notably strong at +48.09%, with price is trading in the lower part of its roughly 52-week range (1.20–7.70), while ATR14 volatility is elevated at roughly 10.80% of price. RSI(14) is 59.6, which keeps short-term momentum constructive without being overly stretched. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains above its signal line, which keeps the momentum structure biased to the upside. The MACD histogram remains positive, although upside momentum is not accelerating further. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. The nearest decision zone is framed by support at 1.80 and resistance at 3.67. A move through resistance would improve the short-term technical tone, while a loss of support would weaken the current structure. Latest fundamentals snapshot: Revenue: 50.21M · Net income: -9.39M · EPS (basic): -0.26. The interactive view adds overlays, pattern context and broader chart structure for deeper review.

Explore more